Molecular-biologic and immunohistochemical features of undifferentiated pleomorphic sarcomas
- Authors: Kosyreva A.M.1,2, Jumaniyazova E.D.1, Dzhalilova D.S.1,2, Sentyabreva A.V.1,2, Miroshnichenko E.A.1,2, Fetisov T.I.3, Lokhonina A.V.1,4
-
Affiliations:
- RUDN University
- Avtsyn Research Institute of Human Morphology of Petrovsky National Research Centre of Surgery
- N.N. Blokhin Russian Cancer Research Center
- National Medical Research Center of Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov
- Issue: Vol 28, No 4 (2024): ONCOLOGY
- Pages: 452-465
- Section: ONCOLOGY
- URL: https://journals.rudn.ru/medicine/article/view/42010
- DOI: https://doi.org/10.22363/2313-0245-2024-28-4-452-465
- EDN: https://elibrary.ru/GTLLVX
Cite item
Full Text
Abstract
Relevance. Undifferentiated pleomorphic sarcoma (UPS) is one of the most common subtypes of soft tissue sarcomas. The polymorphism of tumor cells and high degree of malignancy account for the aggressive potential of UPS. Due to the rarity of occurrence and high heterogeneity of UPS, the number of studies describing the cellular composition and molecular-biological characteristics is very limited. Objective is to assess the cellular composition and gene expression of UPS. Materials and Methods. Biomaterial from 10 patients with UPS was analyzed in the study. In this study we used primary antibodies to CD163 (marker of M2 macrophages) and Fibroblast activation protein (FAP — marker of fibroblasts) and secondary Caprine-Anti-Rabbit IgG HRP were used. HRP-tagged secondary antibodies were manifested using DAB. Antibodies for automated BOND-III IHC stainer were used to evaluate the microenvironment: CD68‑marker of macrophages, CD19‑marker of B-lymphocytes, CD56‑marker of neuroendocrine tumors, metastasis protein, Ki67 antigen-proliferation marker, Bcl‑2‑oncoprotein. Staining on an automated BOND-III IHC stainer was performed according to standard protocols. In homogenized samples of tumor tissue and peritumoral area with the number of cells 106/ml in order to assess the microenvironment of the tumor and surrounding tissue, cytofluorimetric study of the relative number of CD14+ and CD16+ monocytes, CD68+ macrophages, CD86+ M1 macrophages, CD163+ and CD206+ M2 macrophages, CD4+ helper T-lymphocytes and CD45+ leukocytes was performed on the MACS Quant Analyzer device. The mRNA expression levels of HIF1A, VEGF, MMP2, ARG1, NOS2, and EGFR were determined in tumor tissue and peritumoral samples by PCR. The RNA Solo RNA kit was used for RNA isolation, and the MMLV RT Kit was used for reverse transcription. The amplification reaction with real-time detection was performed on a DTprime Real-Time Amplifier. Results and Discussion. The expression of CD56, FAP, CD68 is characteristic for UPS. Among the cells of the microenvironment, macrophages and CD16‑monocytes predominate in UPS. EGFR expression level is increased in tumor cells of the UPS compared to the peritumoral region. The expression levels of ARG1, NOS2, HIF1A, VEGF, and MMP2 in tumors have individual differences and are not specific to the UPS. Conclusion. In our study, we analyzed the cellular composition and gene expression in UPS samples. Further follow-up of patients is necessary to evaluate the clinical significance of each marker.
About the authors
Anna M. Kosyreva
RUDN University; Avtsyn Research Institute of Human Morphology of Petrovsky National Research Centre of Surgery
Email: enar2017@yandex.ru
ORCID iD: 0000-0002-6182-1799
SPIN-code: 5421-5520
Moscow, Russian Federation
Enar D. Jumaniyazova
RUDN University
Author for correspondence.
Email: enar2017@yandex.ru
ORCID iD: 0000-0002-8226-0433
SPIN-code: 1780-5326
Moscow, Russian Federation
Dzhuliia Sh. Dzhalilova
RUDN University; Avtsyn Research Institute of Human Morphology of Petrovsky National Research Centre of Surgery
Email: enar2017@yandex.ru
ORCID iD: 0000-0002-1337-7160
SPIN-code: 3660-5827
Moscow, Russian Federation
Alexandra V. Sentyabreva
RUDN University; Avtsyn Research Institute of Human Morphology of Petrovsky National Research Centre of Surgery
Email: enar2017@yandex.ru
ORCID iD: 0000-0001-5064-219X
SPIN-code: 6966-9959
Moscow, Russian Federation
Ekaterina A. Miroshnichenko
RUDN University; Avtsyn Research Institute of Human Morphology of Petrovsky National Research Centre of Surgery
Email: enar2017@yandex.ru
ORCID iD: 0000-0002-0020-958X
SPIN-code: 2436-4104
Moscow, Russian Federation
Timur I. Fetisov
N.N. Blokhin Russian Cancer Research Center
Email: enar2017@yandex.ru
ORCID iD: 0000-0002-5082-9883
SPIN-code: 6890-8393
Moscow, Russian Federation
Anastasia V. Lokhonina
RUDN University; National Medical Research Center of Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov
Email: enar2017@yandex.ru
ORCID iD: 0000-0001-8077-2307
SPIN-code: 4521-2250
Moscow, Russian Federation
References
- Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17—48. doi: 10.3322/caac.21763
- Fuchs JW, Schulte BC, Fuchs JR, Agulnik M. Targeted therapies for the treatment of soft tissue sarcoma. Front Oncol. 2023;13:1122508. Published 2023 Mar 9. doi: 10.3389/fonc.2023.1122508
- Sun H, Liu J, Hu F. Current research and management of undifferentiated pleomorphic sarcoma/myofibrosarcoma. Front Genet. 2023;14:1109491. Published 2023 Feb 16. doi: 10.3389/fgene.2023.1109491
- Lu Y, Chen D, Wang B. Single-cell landscape of undifferentiated pleomorphic sarcoma. Oncogene. 2024;43(18):1353—1368. doi: 10.1038/s41388-024-03001-8
- Canter RJ, Beal S, Borys D, Martinez SR, Bold RJ, Robbins AS. Interaction of histologic subtype and histologic grade in predicting survival for soft-tissue sarcomas. J Am Coll Surg. 2010;210(2):191—198.e2. doi: 10.1016/j.jamcollsurg.2009.10.007
- Yıldırım S, Çiftdemir M, Ustabaşıoğlu FE, Üstün F, Usta U. Evaluation of the factors affecting survival and local recurrence in thigh soft tissue sarcomas. Jt Dis Relat Surg. 2024;35(1):130—137. doi: 10.52312/jdrs.2023.1289
- Campos M, DE Campos SG, Ribeiro GG. Ki‑67 and CD100 immunohistochemical expression is associated with local recurrence and poor prognosis in soft tissue sarcomas, respectively. Oncol Lett. 2013;5(5):1527—1535. doi: 10.3892/ol.2013.1226
- Atik OŞ. Writing for Joint Diseases and Related Surgery (JDRS): There is something new and interesting in this article!. Jt Dis Relat Surg. 2023;34(3):533. doi: 10.52312/jdrs.2023.57916
- Qian S, Wei Z, Yang W, Huang J, Yang Y, Wang J. The role of BCL‑2 family proteins in regulating apoptosis and cancer therapy. Front Oncol. 2022;12:985363. Published 2022 Oct 12. doi: 10.3389/fonc.2022.985363
- Janik AM, Terlecka A, Spałek MJ. Diagnostics and Treatment of Extrameningeal Solitary Fibrous Tumors. Cancers (Basel). 2023;15(24):5854. doi: 10.3390/cancers15245854
- de Graaff MA, de Rooij MA, van den Akker BE. Inhibition of Bcl‑2 family members sensitises soft tissue leiomyosarcomas to chemotherapy. Br J Cancer. 2016;114(11):1219—1226. doi: 10.1038/bjc.2016.117
- Cancer Genome Atlas Research Network. Electronic address: elizabeth.demicco@sinaihealthsystem.ca; Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017;171(4):950—965.e28. doi: 10.1016/j.cell.2017.10.014
- Dancsok AR, Gao D, Lee AF. Tumor-associated macrophages and macrophage-related immune checkpoint expression in sarcomas. Oncoimmunology. 2020;9(1):1747340. doi: 10.1080/2162402X.2020.1747340
- Van Acker HH, Van Acker ZP, Versteven M. CD56 Homodimerization and Participation in Anti-Tumor Immune Effector Cell Functioning: A Role for Interleukin‑15. Cancers (Basel). 2019;11(7):1029. doi: 10.3390/cancers11071029
- Jaiswal P, Cd A, John JJ. A Spectrum of Histomorphological and Immunohistochemical Expression Profiles of S‑100, CD56 and Calretinin in Benign Peripheral Nerve Sheath Tumours. Cureus. 2023;15(6): e40751. doi: 10.7759/cureus.40751
- Xin L, Gao J, Zheng Z. Fibroblast Activation Protein-α as a Target in the Bench-to-Bedside Diagnosis and Treatment of Tumors: A Narrative Review. Front Oncol. 2021;11:648187. doi: 10.3389/fonc.2021.648187
- Nyström H, Jönsson M, Werner-Hartman L, Nilbert M, Carneiro A. Hypoxia-inducible factor 1α predicts recurrence in high-grade soft tissue sarcoma of extremities and trunk wall. J Clin Pathol. 2017;70(10):879—885. doi: 10.1136/jclinpath‑2016-204149
- Washimi K, Kasajima R, Shimizu E, et al. Histological markers, sickle-shaped blood vessels, myxoid area, and infiltrating growth pattern help stratify the prognosis of patients with myxofibrosarcoma/undifferentiated sarcoma. Sci Rep. 2023;13(1):6744. doi: 10.1038/s41598-023-34026‑w
- Ghalehbandi S, Yuzugulen J, Pranjol MZI, Pourgholami MH. The role of VEGF in cancer-induced angiogenesis and research progress of drugs targeting VEGF. Eur J Pharmacol. 2023;949:175586. doi: 10.1016/j.ejphar.2023.175586
- Ahlén J, Enberg U, Larsson C. Malignant Fibrous Histiocytoma, Aggressive Fibromatosis and Benign Fibrous Tumors Express mRNA for the Metalloproteinase Inducer EMMPRIN and the Metalloproteinases MMP‑2 and MT1-MMP. Sarcoma. 2001;5(3):143—149. doi: 10.1080/13577140120048601